Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targetable Pathways in Advanced Bladder Cancer: FGFR Signaling. | Cancers (Basel) | 2021 | 34638374 | PubTator, text mining | PubMed |
| Preventive Efficacy and Safety of Yiqi-Wenjing-Fang Granules on Oxaliplatin-Induced Peripheral Neuropathy: A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. | Evid Based Complement Alternat Med | 2021 | 34630609 | PubTator, text mining | PubMed |
| The Role of the Carnitine/Organic Cation Transporter Novel 2 in the Clinical Outcome of Patients With Locally Advanced Esophageal Carcinoma Treated With Oxaliplatin. | Front Pharmacol | 2021 | 34603016 | PubTator, text mining | PubMed |
| Wedelolactone protects against cisplatin-induced nephrotoxicity in mice via inhibition of organic cation transporter 2. | Hum Exp Toxicol | 2021 | 34592875 | PubTator, text mining | PubMed |
| FP-ADMET: a compendium of fingerprint-based ADMET prediction models. | J Cheminform | 2021 | 34583740 | PubTator, text mining | PubMed |
| Potential and Limits of Kidney Cells for Evaluation of Renal Excretion. | Pharmaceuticals (Basel) | 2021 | 34577608 | PubTator, text mining | PubMed |
| Multi-Target Actions of Acridones from Atalantia monophylla towards Alzheimer's Pathogenesis and Their Pharmacokinetic Properties. | Pharmaceuticals (Basel) | 2021 | 34577588 | PubTator, text mining | PubMed |
| Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation. | Molecules | 2021 | 34576971 | PubTator, text mining | PubMed |
| 3D-ALMOND-QSAR Models to Predict the Antidepressant Effect of Some Natural Compounds. | Pharmaceutics | 2021 | 34575524 | PubTator, text mining | PubMed |
| Mitochondrial Superoxide Dismutase in Cisplatin-Induced Kidney Injury. | Antioxidants (Basel) | 2021 | 34572961 | PubTator, text mining | PubMed |
| OCT2 pre-positioning facilitates cell fate transition and chromatin architecture changes in humoral immunity. | Nat Immunol | 2021 | 34556886 | PubTator, text mining | PubMed |
Modeling and Simulation for Individualized Therapy of Amisulpride in Chinese Patients with Schizophrenia: Focus on Interindividual Variability, Therapeutic Reference Range and the Laboratory Alert Level. | Drug Des Devel Ther | 2021 | 34548782 | PubTator, text mining | PubMed |
| Establishment of non-small-cell lung cancer risk prediction model based on prognosis-associated ADME genes. | Biosci Rep | 2021 | 34522968 | PubTator, text mining | PubMed |
Pro-Oncogenic c-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione Derivatives. | Front Pharmacol | 2021 | 34512327 | PubTator, text mining | PubMed |
| Properties of Transport Mediated by the Human Organic Cation Transporter 2 Studied in a Polarized Three-Dimensional Epithelial Cell Culture Model. | Int J Mol Sci | 2021 | 34502566 | PubTator, text mining | PubMed |
| In Silico Screening of Novel α1-GABAA Receptor PAMs towards Schizophrenia Based on Combined Modeling Studies of Imidazo [1,2-a]-Pyridines. | Int J Mol Sci | 2021 | 34502550 | PubTator, text mining | PubMed |
| Novel Antiretroviral Therapeutic Strategies for HIV. | Molecules | 2021 | 34500737 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| Detecting Novel Ototoxins and Potentiation of Ototoxicity by Disease Settings. | Front Neurol | 2021 | 34489859 | PubTator, text mining | PubMed |
| Camptothecin shows better promise than Curcumin in the inhibition of the Human Telomerase: A computational study. | Heliyon | 2021 | 34485722 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=36